Journal article
The doses of 10 μg should replace the doses of 5 μg in newborn hepatitis B vaccination in China: A cost-effectiveness analysis
For newborn hepatitis B vaccination in China, the 10 μg strategy should be cost-effective, even more possibly highly cost-effective or cost-saving compared with the current 5 μg strategy. The doses of 10 μg should be considered to replace the doses of 5 μg in newborn hepatitis B vaccination in China.
Authors
Languages
- English
Publication year
2015
Journal
Vaccine
Volume
31
Type
Journal article
Categories
- Programme management
Diseases
- Hepatitis B
Countries
- China
Tags
- New vaccine introduction
- Planning, budgeting and financing
WHO Regions
- Western Pacific Region